ANTITUMOR POLYSACCHARIDE-INDUCED TUMOR-REGRESSING FACTOR IN THE SERUM OF TUMOR-BEARING MICE - PURIFICATION AND CHARACTERIZATION
- 1 January 1986
- journal article
- research article
- Vol. 5 (3) , 225-235
Abstract
Marked tumor-regressing activity was induced in the serum of S180 tumor-bearing mice by injection of an antitumor polysaccharide, CM-TAK [carboxymethylated .beta.(1-3)glucan]. Maximal activity was induced 7-14 days after the tumor transplantation and 10-12 h after CM-TAK treatment. A quantitative assay for the activity was established on the basis of the initial decrease in the number of the tumor cells within 24 h. The factor with tumor-regressing activity was purified 10,000-fold by the series of hydroxylapatite chromatography, ammonium sulfate precipitation, anion-exchange chromatography, gel filtration, and boronate-mediated affinity chromatography. The molecular weight was estimated to be 250,000 by gel filtration. The activity was proteinase K sensitive, but relatively resistant to trypsin. Neuraminidase did not affect the activity. It is believed that the tumor-regressing factor is different from the tumor necrosis factor.This publication has 17 references indexed in Scilit:
- Rabbit tumor necrosis factor: mechanism of actionInfection and Immunity, 1981
- Purification and physico-chemical characterization of rabbit tumor necrosis factor.The Journal of Immunology, 1980
- Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cellsInfection and Immunity, 1980
- Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells.The Journal of Immunology, 1980
- Antitumor activity of carboxymethylglucans obtained by carboxymethylation of (1→3)-β-d-glucan from Alcaligenes faecalis var. myxogenes IFO 13140Published by Elsevier ,1979
- The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity.The Journal of Experimental Medicine, 1978
- The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity.The Journal of Experimental Medicine, 1978
- DEPENDENCE ON CHAIN-LENGTH OF ANTI-TUMOR ACTIVITY OF (1-]3)-BETA-D-GLUCAN FROM ALCALIGENES-FAECALIS VAR MYXOGENES, IFO 13140, AND ITS ACID-DEGRADED PRODUCTS1978
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Identification of a reticuloendothelial stimulating agent in zymosanAmerican Journal of Physiology-Legacy Content, 1961